Halozyme Therapeutics
Jennifer Brooks has over 20 years of experience in drug safety and pharmacovigilance. Since August 2015, Jennifer has served as Sr. Manager of Drug Safety and Pharmacovigilance Operations at Halozyme Therapeutics, Inc., after progressing through roles such as Manager and Sr. Drug Safety Specialist. Prior experience includes a Senior Safety Associate position at Agility Clinical, Inc., and a Drug Safety Independent Consultant role at Medical Affairs 360. Jennifer's earlier career includes significant contributions at Amylin Pharmaceuticals, LLC, and Biogen Idec, focusing on case management, safety report preparation, and data accuracy for clinical trials. Jennifer holds degrees from National University and UC San Diego.
This person is not in the org chart
This person is not in any teams
Halozyme Therapeutics
7 followers
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.